INIS
amino acid sequence
24%
antibodies
24%
blood
11%
cam
15%
cancer
11%
comparative evaluations
13%
concentration
9%
control
11%
coronaviruses
28%
covid-19
15%
delivery
17%
detection
44%
diseases
34%
dna
9%
drugs
16%
genes
32%
genetics
13%
hiv
32%
hospitals
16%
humans
62%
indonesia
92%
infants
12%
influenza
9%
inhibition
8%
laboratories
29%
leukemia viruses
17%
management
9%
measles virus
40%
nucleoproteins
8%
nucleotides
21%
patients
27%
pcr
36%
proteins
53%
purification
16%
rats
14%
receptors
9%
risks
21%
rna
23%
specificity
9%
spine
17%
strains
22%
symptoms
11%
transmission
11%
tumor necrosis factor
11%
vaccines
60%
values
11%
variations
10%
venoms
17%
viruses
82%
workers
8%
Keyphrases
AIDS/HIV
11%
Amino Acid Sequence
27%
Associated Diseases
11%
Cervical Cancer
11%
Clinical Manifestations
9%
Clinical Symptoms
7%
Clostridium Perfringens
17%
COVID-19
36%
Cross-reactivity
8%
Crown-of-thorns Starfish Acanthaster Planci
7%
Escherichia Coli
10%
H Protein
8%
H5N1
17%
Hemaglutinin
8%
HIV RNA
11%
HPV16
11%
Human Detection
11%
Human Immunodeficiency Virus Type 1 (HIV-1)
21%
Human Serum
7%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
23%
Indonesia
100%
Indonesian
11%
Infectious Diseases
9%
Influenza A/H5N1 Virus
11%
Jakarta
24%
Leukemia Virus
12%
Measles Virus
40%
N Gene
9%
N Protein
15%
Nucleotide Sequence
8%
Phospholipase A2 (PLA2)
21%
Plasma Samples
8%
Plasmid
8%
Provirus
7%
Quantitative PCR
17%
Recombinant
14%
Risk Factors
11%
RT-PCR Assay
11%
Scoring System
11%
Sequence Difference
11%
Serological Test
11%
Severe Acute Respiratory Syndrome-associated Coronavirus
11%
Sialidase
17%
Spine
17%
Tumor Necrosis Factor-α
11%
Universitas Indonesia
12%
Vaccine Virus
31%
Venom
17%
Virus
32%
Virus Strains
8%
Immunology and Microbiology
Amino Acid Sequence
19%
Antibody Response
6%
Blood Plasma
8%
Candida
6%
Central Nervous System
5%
Cladistics
12%
Clostridium perfringens
11%
Coronavirinae
11%
Cross-Reactivity
7%
ELISA
8%
Embryonated
5%
Epitope
17%
Escherichia coli
12%
Human Immunodeficiency Virus
30%
Human Immunodeficiency Virus 1
23%
Human Immunodeficiency Virus Infection
6%
Human Papillomavirus Type 16
11%
Human T-Lymphotropic Virus 1
23%
Human T-Lymphotropic Virus 2
7%
Immunoassay
5%
Immunodiagnostics
7%
Immunoglobulin M
5%
In Ovo
5%
Inbred Strain
7%
Influenza A Virus (H5N1)
6%
Long Terminal Repeat
7%
Measles Vaccine
28%
Measles Virus
26%
Newcastle Disease Virus
5%
Nucleoprotein
9%
Nucleotide Sequence
14%
Peptides
5%
Provirus
7%
Real Time Polymerase Chain Reaction
5%
Reverse Transcription Polymerase Chain Reaction
12%
Serology
9%
Serum (Blood)
5%
Severe Acute Respiratory Syndrome
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Simian T-Lymphotropic Virus 1
6%
Strain Identification
6%
T Cell
8%
Toxoplasma gondii
5%
Tumor Necrosis Factor
5%
Tumor Necrosis Factor Alpha
11%
Viral Replication
5%
Virus
42%
Virus Nucleocapsid
13%
Virus Vaccine
17%
Wild Type
23%